Discovery points to new approach to treating liver cancer

WEST LAFAYETTE — A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug, which currently prolongs the life of liver cancer patients for only two to three months. A study of the r ...

Related Keywords

Japan ,France ,China ,Mary Martialay ,Ourania Andrisani ,Purdue Institute For Cancer Research ,Cancer Research Center ,College Of Veterinary Medicine At Purdue University ,China Pharmaceutical University ,Professor Of Basic Medical Sciences ,National Institutes Of Health ,Cell Death ,Distinguished Professor ,Basic Medical Sciences ,Veterinary Medicine ,Purdue Institute ,Cancer Research ,China Pharmaceutical ,National Institutes ,